Hyper activation of the NFκB pathway involves the survival, activation, and differentiation of innate immune cells, inflammatory T cells and has been implicated in the pathogenesis of severe/critical COVID-19 patients [77]. The gene discussed is NFKB1; the disease is COVID-19.